These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9972842)

  • 41. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
    Feifel D; Reza T; Robeck S
    Neuropsychopharmacology; 1999 Feb; 20(2):141-9. PubMed ID: 9885794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA; Boyar WC
    Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Devazepide increases food intake in male but not female Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1996 Jul; 60(1):273-5. PubMed ID: 8804675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine.
    Nelson CL; Wetter JB; Milovanovic M; Wolf ME
    Neuroscience; 2007 Apr; 146(1):41-9. PubMed ID: 17321058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
    Lu L; Zhang B; Liu Z; Zhang Z
    Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for CCK(A) receptor involvement in the acquisition of conditioned activity produced by cocaine in rats.
    Josselyn SA; De Cristofaro A; Vaccarino FJ
    Brain Res; 1997 Jul; 763(1):93-102. PubMed ID: 9272833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The CCK-system underpins novelty-seeking behavior in the rat: gene expression and pharmacological analyses.
    Ballaz SJ; Akil H; Watson SJ
    Neuropeptides; 2008 Jun; 42(3):245-53. PubMed ID: 18410964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor.
    Zager A; Mennecier G; Palermo-Neto J
    Behav Brain Res; 2012 Jun; 232(1):30-6. PubMed ID: 22487249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
    Weiss F; Tanzer DJ; Ettenberg A
    Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facilitation and inhibition of feeding by a single dose of amphetamine: relationship to baseline intake and accumbens cholecystokinin.
    Sills TL; Vaccarino FJ
    Psychopharmacology (Berl); 1991; 105(3):329-34. PubMed ID: 1798830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presynaptic dopaminergic neurotransmission mediates amphetamine-induced unconditioned but not amphetamine-conditioned locomotion and defecation in the rat.
    Di Lullo SL; Martin-Iverson MT
    Brain Res; 1991 Dec; 568(1-2):45-54. PubMed ID: 1726071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex.
    Peleg-Raibstein D; Feldon J
    Behav Brain Res; 2008 Jan; 186(1):12-22. PubMed ID: 17884189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of cocaine sensitization: regulation by the medial prefrontal cortex.
    Prasad BM; Hochstatter T; Sorg BA
    Neuroscience; 1999; 88(3):765-74. PubMed ID: 10363816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Hayes DJ; Mosher TM; Greenshaw AJ
    Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individual responses to novelty predict qualitative differences in d-amphetamine-induced open field but not reward-related behaviors in rats.
    Antoniou K; Papathanasiou G; Panagis G; Nomikos GG; Hyphantis T; Papadopoulou-Daifoti Z
    Neuroscience; 2004; 123(3):613-23. PubMed ID: 14706774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.